In addition, IHC of retinoblastoma protein (Rb) and p16 might be helpful in predicting adverse outcomes due to divergent aberrations in the Rb/p16/cyclin D1 pathway among low- and high-grade neuroendocrine tumors [14,15,16]. Here, RB1 is linked to neuroendocrine neoplasm.